Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.9666
-0.0635 (-6.16%)
May 14, 2025, 4:00 PM - Market closed
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $37.61 million as of May 14, 2025. Its market cap has increased by 0.72% in one year.
Market Cap
37.61M
Enterprise Value
37.06M
1-Year Change
0.72%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $37.61M, an increase of 2,015.90%. That is a compound annual growth rate of 228.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 37.25M | -14.19% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |